(Q41757587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Molecular pathogenesis of sporadic and familial forms of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Alison Goate

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

F Ashall

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

Trends in Molecular Medicine

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

151-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Normal and abnormal biology of the beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Exploring the etiology of Alzheimer disease using molecular genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Apolipoprotein E and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Presenilins: genes for life and death

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

The genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Brain parenchymal and microvascular amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Inflammation and Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Microglial in neurodegenerative disorders: emphasis on Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

A comparison of familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

A mitochondrial DNA clone is associated with increased risk for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

Human apolipoprotein E: the Alzheimer's disease connection.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43)

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901229-5

7 January 2021

10.1016/S1357-4310(98)01229-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572056%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference